Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Clinical trials showing treatment of ovarian cancer with anti-TIM-3 antibodies (https://clinicaltrials.gov/, accessed on 27 September 2022).
| Drug Name | Drug Type | Combination Agents | Phase | Clinical Trial Number | Status |
|---|---|---|---|---|---|
| INCAGN02390 | anti-TIM-3 | - | I | NCT03652077 | Completed |
| MBG453 (Sabatolimab) | anti-TIM-3 | PDR001 (spartalizumab), Decitabine | I-Ib/II | NCT02608268 | Terminated |
